| P50 | author | Hideho Okada | Q90417075 |
| | Gary Kohanbash | Q56851926 |
| P2093 | author name string | Ronald L Hamilton | |
| | Ian F Pollack | |
| | Heather A McDonald | |
| | Keri L Low | |
| P2860 | cites work | Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin | Q81156941 |
| | Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation | Q22011187 |
| | Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors | Q24801526 |
| | Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain | Q28201859 |
| | IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis | Q28285105 |
| | Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo | Q28575777 |
| | Diffuse brain stem glioma. A review of stereotactic biopsies | Q30578855 |
| | Eph receptors and ephrin ligands: embryogenesis to tumorigenesis | Q34103639 |
| | Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses. | Q40272726 |
| | EphA2 as a novel molecular marker and target in glioblastoma multiforme | Q40357219 |
| | EphA2 as a glioma-associated antigen: a novel target for glioma vaccines | Q40365151 |
| | Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment | Q40400501 |
| | Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells. | Q40479866 |
| | Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells | Q40671741 |
| | Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway | Q40808897 |
| | Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen. | Q40860001 |
| | Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms | Q41005830 |
| | Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy | Q41131696 |
| | Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. | Q44172489 |
| | Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. | Q44308408 |
| | Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma | Q44980797 |
| | Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine | Q45861094 |
| | Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity | Q45867628 |
| | Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response | Q45875994 |
| | Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells | Q45879265 |
| | Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin | Q46825564 |
| | Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy | Q48209862 |
| | Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial | Q48232854 |
| | A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma | Q48376724 |
| | Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer | Q48382544 |
| | Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index | Q48867858 |
| | Brain stem gliomas:An autopsy study of 25 cases | Q48966397 |
| | Inhibitor of apoptosis protein survivin regulates vascular injury. | Q52546976 |
| | Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. | Q54039393 |
| | Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors. | Q55471967 |
| | Intrinsic brainstem tumors in childhood: surgical indications. | Q55485892 |
| | Pediatric Brain Stem Tumors: Radiographic, Pathological, and Clinical Correlations | Q55489416 |
| | Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo | Q71091026 |
| | Brain tumors in children | Q72827847 |
| | Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients | Q73548917 |
| | Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients | Q74379461 |
| P433 | issue | 3 | |
| P304 | page(s) | 245-250 | |
| P577 | publication date | 2008-03-07 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas | |
| P478 | volume | 88 | |